SUMMARY In a series of pregnant women with iron deficiency anaemia treated by a total dose infusion of iron dextran, the non-haem iron content of the placenta at term was studied histochemically and by chemical analysis. Within a few days of the infusion the Prussian blue reaction on the placenta was very strong, but was negative by ten days after the infusion. Chemical analysis showed that both the water-insoluble fraction (haemosiderin) and the water-soluble fraction (ferritin) of the non-haem iron were increased soon after the infusion, but three weeks after the infusion they were almost the same as in untreated controls. Pinocytosis of iron dextran by the trophoblast and increased transport of transferrin-bound iron to the placenta are considered as possible causes for this large uptake of iron by the placenta.
The histochemical examination of a placenta obtained from a stillbirth which occurred three days after the mother had received a total dose infusion of iron dextran, at 32 wk gestation, revealed very large amounts of haemosiderin in the trophoblast. This is in contrast to the findings of Pathak et all who concluded from a study of a large series of irondeficient patients treated with total dose infusion of iron dextran that there was no resulting increase of stainable iron in the placenta. There are two features of the stillborn baby which may have contributed to the accumulation of an unusually large amount of haemosiderin in the placenta. First, the foetus was macerated, so that transfer of iron to the foetus must have ceased soon after the infusion, and secondly, the gestational age of the placenta was only 32 wk when it was examined. Further studies were therefore made to assess in more detail the effect on placental iron of infusions of iron dextran given at different stages of pregnancy. In addition to histochemical examination of the placenta, the two forms of storage iron, haemosiderin and ferritin, were estimated respectively as the water-insoluble and water-soluble fractions of the non-haem iron. Non-haem iron For the estimation of non-haem iron the amnion and chorion were removed from the rest of the placenta which was then blotted dry between layers of filter paper and the whole of it was homogenised. The homogenate was again blotted dry to remove released blood and a weighed aliquot was shaken for 15 min with water, which had been deionised and then glass-distilled, to extract the water-soluble iron. After centrifugation the supernatant was removed for estimation of its iron content and the deposit was extracted once more with water. The Effect of total dose injusion of iron dextran on the storage iron content of the human placenta pooled extracts were heated with hydrochloric acid and the iron content estimated with 1,10-phenanthroline. 2 The residue from the above procedure was ground with powdered silica which had been washed with hot hydrochloric acid to remove iron. To extract the water-insoluble iron a solution of saturated sodium pyrophosphate was added followed by trichloracetic acid and the mixture heated in a boiling water bath.4 After cooling and centrifugation the supernatant was removed, the residue was extracted twice more and all the extracts were combined. The iron content was measured as above.
The dry weight was determined by drying a second weighed aliquot in an oven at 95°C.
Serum iron
Serum iron was estimated by the method of Ramsay;5 in the presence of circulating iron dextran a 60-min period of heating was used, instead of the usual five minutes, to release the iron from the dextran.
Results
The interval between the infusion and the onset of delivery varied greatly. One patient was delivered the same day and several others went into labour within 10 days, but in most cases the infusion was given more than three weeks before delivery. cases the difference was less than 6%. The mean of the duplicates was therefore taken.
In 11 controls the placental haemosiderin iron ranged from 4 2 to 12 mg/100 g dry weight (0 076-0 216 mmol). In 26 specimens obtained after iron dextran infusion the placental haemosiderin ranged from control levels up to 128 mg (2 30 mmol)/100 g dry weight. The highest values were all found in placentas obtained within two weeks of the infusion, very much lower concentrations occurring in placentas collected between three and 20 wk after the infusion (Fig. 2) .
However, the high concentrations found within two weeks of the infusion were very variable. Two placentas were obtained four days after the infusion, two others at six days and two at 12 days. There were large differences in haemosiderin iron within each of these pairs. In two of the pairs the differences could be related to differences in the dose of iron dextran, but the remaining pair came from a twin pregnancy and were hence exposed to the same maternal blood level.
The general relation between the placental haemosiderin iron concentrations and the dose of iron dextran is illustrated in Fig. 3 . All but two of the highest concentrations were. associated with the largest doses but they were also cases in which the B3auminiger, W'alters, WVhiclicr, Dukec These results are in agreement with those on several other species7 8 but not with another study on the human placenta in which it was concluded that there was no increase of Prussian blue-positive material after a therapeutic infusion of Imferon.' In fact, all but a small number of our cases were similarly negative for haemosiderin histochemically, the increased iron content being shown only by chemical analysis.
The mechanism by which placental iron increases is uncertain but two processes seem likely to contribute. The first is the increased transport to the placenta of iron bound to transferrin. The amount of iron available to be carried to the fetus in this way increases as the iron is split from the dextran moiety in the reticuloendothelial system; this probably occurs quite rapidly, as the half-life of iron dextran in the plasma of the patients was about 42 h.i Increased amounts of iron may therefore be taken up by the placenta via specific transferrin receptors9 and reconverted temporarily into storage forms.
Another possibility is that Imferon itself is taken up and degraded by the trophoblast. Electron microscopic evidence for this was adduced by Muir' 0 who found, in the human trophoblast, pinocytotic vesicles containing electron-dense material identical with vesicles found in cells of the reticuloendothelial system of monkeys after total dose infusion of iron dextran; such vesicles were never seen in controls. The rate of accumulation of storage iron in the placenta is consistent with this as it has been shown in both pregnant and nonpregnant humans that the accumulation of iron in the reticuloendothelial system reaches a maximum about 4-6 days after infusion."1 3 The relative contributions of these two processes to the total iron uptake is speculative. However, it was found in women that after infusion of 59Fe-labelled iron dextran counts of radioactivity over the uterus reached a maximum at 10 min and never exceeded counts over the heart.'3 This suggests that the total uptake by the feto-placental unit is small, though it must be remembered that the placenta contains a relatively large amount of blood.
Wohler8 found that the storage iron content of the human placenta was related to the maternal serum iron concentration in that placental concentrations were slightly lower in mothers who were irondeficient than in those who were not. It is of interest therefore that in the present study increased amounts of iron in the placenta were usually associated with abnormally high concentrations of maternal serum iron. The latter were due to incomplete clearance of iron dextran from the circulation by the time of delivery6 which makes it likely that the maternal iron stores would still have been replete with iron, available to be transported to the placenta by transferrin.
There appears to be no information available on what happens to the iron when it disappears from the placenta. The presumption is that most of it will be transferred to the fetus, and there is evidence that the total iron transferred across the placenta after total dose infusion of iron dextran is, at least in some patients, greater than normal. 
